Mi az ára Wuhan Hiteck Biological Pharma Co.,Ltd (300683)

Wuhan Hiteck Biological Pharma Co.,Ltd (300683) ára $3.71

Mi a Wuhan Hiteck Biological Pharma Co.,Ltd (300683 piaci tőkésítése)

Wuhan Hiteck Biological Pharma Co.,Ltd piaci tőkésítése (300683) $486.16M

Wuhan Hiteck Biological Pharma Co.,Ltd (300683) Egy Részvényre Jutó Nyereség

Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise operating in China, primarily engaged in the research, development, manufacturing, and commercialization of bio-engineered products and lyophilized injectable medications. The company's extensive product portfolio encompasses a variety of pharmaceutical solutions, such as Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye acyclovir tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository; Xunkeyuan tinidazole suppository; and Shufu nimodipine sustained-release tablets. Beyond therapeutics, Wuhan Hiteck also provides a comprehensive array of diagnostic kits. These include tests for measles virus and rubella virus nucleic acid, mycoplasma isolation and identification, bacterial vaginosis rapid detection, measles virus IgG antibodies, and the coronavirus N-protein. Furthermore, the firm supplies active pharmaceutical ingredients (APIs) and their chemical intermediates, notably Lopinavir and Ritonavir. Its core therapeutic areas of focus are the nervous system and oncology. Established in 1992, Wuhan Hiteck Biological Pharma Co.,Ltd is headquartered in Wuhan, China.

Év	EPS	Változtassa meg
Nincs elég adat a megadott dátumokhoz.

Év

EPS

Változtassa meg

Nincs elég adat a megadott dátumokhoz.

Vállalat	EPS	EPS különbség	Ország
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$0.56	-	IN
Galderma Group AG GALD.SW	-	-	CH

Vállalat

EPS

EPS különbség

Ország